China NMPA Product Recall - Single-photon emission computed tomography (SPECT) system; single-photon emission computed tomography and X-ray computed tomography imaging system; single-photon emission computed tomography and X-ray computed tomography imaging system

China NMPA product recall for Single-photon emission computed tomography (SPECT) system; single-photon emission computed tomography and X-ray computed tomography imaging system; single-photon emission computed tomography and X-ray computed tomography imaging system by GE Healthcare Systems Trade Development (Shanghai) Co., Ltd. published December 31, 2020. Recall level: Level 2 Recall. The National Medical Products Administration (NMPA) announced on December 31, 2020, that GE Healthca

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

GE Healthcare Systems Trade Development (Shanghai) Co., Ltd.

Inspection Date

Unknown Date

Product Type

ID: f091fe6f-19ff-4cad-b04f-79636eff5e2c

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox